Aslam Ejaz
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
Papers in
- Co-authors
- Timothy M. Pawlik (108 shared papers)Gaya Spolverato (63 shared papers)Timothy M. Pawlik (110 shared papers)Jordan M. Cloyd (143 shared papers)Yuhree Kim (49 shared papers)Mary Dillhoff (79 shared papers)Allan Tsung (59 shared papers)Timothy M. Pawlik (32 shared papers)
- Journals
- Journal of Gastrointestinal Surgery (44 papers)Annals of Surgical Oncology (44 papers)Journal of Surgical Oncology (30 papers)HPB (27 papers)Surgery (22 papers)
- Partner nations
- United StatesItalyChina
In The Last Decade
Aslam Ejaz
291 papers receiving 6.2k citations
Aslam Ejaz's Hit Papers
Peers
Comparison fields: 5 of 126
- Hepatology 515
- Oncology 1.7k
- Biochemistry 294
- Surgery 1.8k
- Health Informatics 52
Countries citing papers authored by Aslam Ejaz
This map shows the geographic impact of Aslam Ejaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aslam Ejaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aslam Ejaz more than expected).
Fields of papers citing papers by Aslam Ejaz
This network shows the impact of papers produced by Aslam Ejaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aslam Ejaz. The network helps show where Aslam Ejaz may publish in the future.
Co-authors
The 25 scholars most cited alongside Aslam Ejaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 308 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Telemedicine: Patient-Provider Clinical Engagement During the COVID-19 Pandemic and Beyond Hit paper breakdown → | 2020 | 254 |
| 2 | 2014 | 140 | |
| 3 | 2019 | 133 | |
| 4 | 2021 | 122 | |
| 5 | 2015 | 117 | |
| 6 | 2014 | 110 | |
| 7 | 2020 | 99 | |
| 8 | 2019 | 96 | |
| 9 | 2014 | 96 | |
| 10 | 2014 | 94 | |
| 11 | 2014 | 88 | |
| 12 | 2015 | 85 | |
| 13 | 2015 | 84 | |
| 14 | 2020 | 83 | |
| 15 | 2015 | 76 | |
| 16 | 2015 | 67 | |
| 17 | 2017 | 66 | |
| 18 | 2014 | 64 | |
| 19 | 2014 | 60 | |
| 20 | 2017 | 60 |
About Aslam Ejaz
Aslam Ejaz is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Hepatology and Public Health, Environmental and Occupational Health, having authored 308 papers that have together received 6.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (70 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers), Gastric Cancer Management and Outcomes (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (23 papers), Blood transfusion and management (15 papers), Colorectal Cancer Surgical Treatments (13 papers), Gallbladder and Bile Duct Disorders (12 papers) and Neuroendocrine Tumor Research Advances (12 papers). The work is most often cited by research in Hepatology (515 citations), Oncology (1.7k citations), Biochemistry (294 citations), Surgery (1.8k citations) and Health Informatics (52 citations). Aslam Ejaz has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Timothy M. Pawlik, Gaya Spolverato, Timothy M. Pawlik, Jordan M. Cloyd, Yuhree Kim, Mary Dillhoff, Allan Tsung, Timothy M. Pawlik, Shishir K. Maithel and Diamantis I. Tsilimigras. Their work appears in journals such as Journal of Gastrointestinal Surgery, Annals of Surgical Oncology, Journal of Surgical Oncology, HPB and Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.